Table: radiopharmacology
[['name', 'investigation', 'route of administration', 'in - vitro / in - vivo', 'imaging / non - imaging'], ['in111 - dtpa ( diethylenetriaminepenta - acetic acid )', 'ventriculo - peritoneal shunt (laveen shunt)', 'intraperitoneal injection', 'in - vivo', 'imaging'], ['in111 - dtpa ( diethylenetriaminepenta - acetic acid )', 'cisternography', 'intra - cisternal', 'in - vivo', 'imaging'], ['in111 - s leukocyte', 'infection / inflammation imaging', 'iv', 'in - vivo', 'imaging'], ['in111 - s platelet', 'thrombus imaging', 'iv', 'in - vivo', 'imaging'], ['in111 - pentetreotide', 'somatostatin receptor imaging', 'iv', 'in - vivo', 'imaging'], ['in111 - octreotide', 'somatostatin receptor imaging ( octreoscan )', 'iv', 'in - vivo', 'imaging']]
Statement: In111 - S Leukocyte , In111 - S Platelet , In111 - Pentetreotide and In111 - Octreotide all have Iv as the Route Of Administration
Statement: In111 - Pentetreotide and In111 - Octreotide are In - Vivo and Imaging , and have Investigation of Somatostatin Receptor Imaging
Statement: In111 - Dtpa ( Diethylenetriaminepenta - Acetic Acid ) has 2 Investigation of Ventriculo - Peritoneal Shunt (laveen Shunt) and of Cisternography
Statement: In - Vitro / In - Vivo was In - Vivo for all on the list , and all is Imaging , likewise
Statement: Iv is the Route Of Administration for 4 , with 1 Intraperitoneal Injection and 1 Intra - Cisternal